
Trump Announces Phased Tariffs on Generic Drugs to Push Onshore Production
President Trump announced a new tariff schedule for generic drugs, starting with two years of zero tariffs, then a 100% levy in August 2028, rising to 200% in 2029. This policy aims to incentivize generic drugmakers to move production to the U.S., significantly impacting countries like India, which supplies nearly 50% of U.S. generic medicines.

















